Category Specific RSS

Opinion

Stocks to trade through August Reporting Season – Emerald Financial Webcast

US earnings season is wrapping up and it’s been a wild one - with most of the S&P500 beating their…

6 years ago

Boom or bust: retailing’s two-speed economy

Shoppers engaging in retail therapy despite the spectre of even more serious job losses and mounting evidence the virus is…

6 years ago

Silver ratio returns to key level

It can’t be this easy, can it? There is a large community of traders who focus purely on trading precious…

6 years ago

Hydrogen: an expensive bomb or a multibillion dollar opportunity?

Australia’s chief scientist Alan Finkel describes hydrogen as “Australia’s next multibillion dollar export opportunity’’ - and judging from two recent…

6 years ago

The stocks struggling with Victoria’s rise in cases

“The place to be”? Not for many ASX listed stocks who are copping a hit from a second wave of…

6 years ago

IPO Watch July: Aroa Biosurgery

Soft tissue regeneration company, Aroa Biosurgery, is set to list on the ASX at the end of the month. The…

6 years ago

The New Criterion: the IPOs forging ahead in the coronavirus era

The coronavirus has pulled the plug on many proposed initial public offers (IPOs), with the Australian Securities Exchange’s ‘upcoming listings’…

6 years ago

The New Criterion: the niche stocks flying the flag for Australian manufacturing

Our trade tensions with China have fuelled the coronavirus-spurred debate about our reliance on offshore supply chains for goods both…

6 years ago

Weak earnings expectations and recovered prices put US shares in difficult position

With a US company earnings season for the second quarter kicking off this week, US shares are in a difficult…

6 years ago

Research Note: Speculative Buy on Crowd Media (ASX: CM8)

The Advisors at Emerald Financial recently released a Speculative Buy report on Crowd Media (ASX: CM8). The Company has benefited…

6 years ago